Needham analyst Mike Matson lowered the firm’s price target on Boston Scientific (BSX) to $77 from $97 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BSX:
- Boston Scientific price target lowered to $85 from $90 at Truist
- Boston Scientific upgraded to Buy from Hold at Nephron Research
- Boston Scientific price target lowered to $78 from $86 at Baird
- Boston Scientific price target lowered to $75 from $94 at Wells Fargo
- Boston Scientific price target lowered to $96 from $100 at Barclays